- High Risk: Patients aged less than 3 years, with a residual tumor that is larger than 1.5 cms in size, and with visible evidence of CSF spread, are categorized within the high risk group.
Out of all confirmed Medulloblastoma patients, approximately two-thirds get classified as standard-risk, and the remaining one-third of such patients are categorized as high-risk.
What are the treatment options for Medulloblastoma?
Treatment for Medulloblastoma includes general measures to decrease intracranial pressure, followed by specific treatment to fight the tumor.